Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

BARR PHARMACEUTICALS INC (BRL) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.05 Metrics
OS: 107.9 M 7 % ROE
Market cap: $5.4 M 10 % ROIC
Net debt: $1.32 B 1.9 x Debt/EBITDA
EV: $1.33 B

 
TTM Valuation
EBITDA $684 M 1.9 x EV/EBITDA
EBIT $365 M 3.6 x EV/EBIT
EPS $1.39 0.0 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-07Jun-30-06Jun-30-05Jun-30-04Jun-30-03Jun-30-02
Revenues2,500.61,314.51,047.41,309.1902.91,189.0
            Revenue growth 25.5%-20.0%45.0%-24.1% 
Cost of goods sold1,171.1377.9317.4632.7424.1676.3
Gross profit1,329.5936.6730.0676.3478.8512.7
            Gross margin53.2%71.3%69.7%51.7%53.0%43.1%
Selling, general and administrative763.8308.8285.2314.5161.0111.9
Research and development248.5140.2128.4169.091.275.7
EBIT317.2487.6316.3192.8226.6325.1
            EBIT margin12.7%37.1%30.2%14.7%25.1%27.3%
Pre-tax income207.8522.9329.9194.4262.7337.5
Income taxes64.5186.5114.971.395.1125.3
            Tax rate31.1%35.7%34.8%36.7%36.2%37.1%
Earnings from continuing ops142.1336.5215.0123.1167.6210.3
Earnings from discontinued ops-13.8     
Net income128.4336.5215.0123.1167.6210.3
            Net margin5.1%25.6%20.5%9.4%18.6%17.7%
 
Diluted EPS$1.31$3.12$2.03$1.15$1.62$2.06
Shares outstanding (diluted)108.6107.8106.1106.7103.6102.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy